Immunization strategies for the control of serogroup C meningococcal disease in developed countries.
about
Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection.Meningococcal glycoconjugate vaccines.Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlersPersistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infantsPrevention of meningococcal serogroup C disease by NeisVac-C.
P2860
Immunization strategies for the control of serogroup C meningococcal disease in developed countries.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Immunization strategies for th ...... isease in developed countries.
@ast
Immunization strategies for th ...... isease in developed countries.
@en
type
label
Immunization strategies for th ...... isease in developed countries.
@ast
Immunization strategies for th ...... isease in developed countries.
@en
prefLabel
Immunization strategies for th ...... isease in developed countries.
@ast
Immunization strategies for th ...... isease in developed countries.
@en
P2860
P356
P1476
Immunization strategies for th ...... isease in developed countries.
@en
P2093
Philippe De Wals
P2860
P304
P356
10.1586/14760584.5.2.269
P577
2006-04-01T00:00:00Z